Skip to main content Skip to navigation
Menu
800-789-7366

Health Alert:

See the latest Coronavirus Information including testing sites, visitation restrictions, appointments and scheduling, and more.

within
I am searching for a
Reset Form

Robert G. Maki, MD, PhD

Hematology, Medical Oncology
Robert G. Maki, MD, PhD
No patient ratings. Why not?
Why doesn't this doctor have a rating?

There is no publicly available rating for this medical professional for one of the following reasons:

  1. He or she is not employed by Penn Medicine.
  2. He or she does not see patients in a medical practice setting.
  3. He or she sees patients but has not yet received the minimum 30 patient satisfaction reviews in the past 12 months, ensuring that the rating is statistically reliable and a true reflection of patient satisfaction.

Sees Adults (18-65), Geriatrics (65+)

Robert G. Maki, MD, PhD

Hematology, Medical Oncology
No patient ratings. Why not?
Why doesn't this doctor have a rating?

There is no publicly available rating for this medical professional for one of the following reasons:

  1. He or she is not employed by Penn Medicine.
  2. He or she does not see patients in a medical practice setting.
  3. He or she sees patients but has not yet received the minimum 30 patient satisfaction reviews in the past 12 months, ensuring that the rating is statistically reliable and a true reflection of patient satisfaction.

Sees Adults (18-65), Geriatrics (65+)

  • Clinical Director, Sarcoma Program
  • Professor of Medicine at the Hospital of the University of Pennsylvania
  • Dr. Maki is employed by Penn Medicine.
Accepting new patients
Call 800-789-7366 Request Callback

Meet Dr. Maki

I am a medical oncologist with expertise in tumors arising from connective tissues, which include sarcomas and other aggressive tumors that do not metastasize, such as desmoid tumors. These tumors represent less than 1% of all cancers that happen in adults, I work with patients to find the right treatment for all of the 70+ types of bone and soft tissue sarcomas and other soft tissue tumors, and for other cancers as well, a field called developmental therapeutics.

In my research, I seek to find new medications that may be useful for sarcoma patients, and try to figure out why they work or not. I work closely with colleagues at Penn Medicine, the Children's Hospital of Philadelphia, and with other national and international teams of researchers to improve the understanding and treatment of sarcomas.

Back To Top